CY1110358T1 - Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης - Google Patents

Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης

Info

Publication number
CY1110358T1
CY1110358T1 CY20091100839T CY091100839T CY1110358T1 CY 1110358 T1 CY1110358 T1 CY 1110358T1 CY 20091100839 T CY20091100839 T CY 20091100839T CY 091100839 T CY091100839 T CY 091100839T CY 1110358 T1 CY1110358 T1 CY 1110358T1
Authority
CY
Cyprus
Prior art keywords
hysteron
removal
piperazine derivatives
substituted propenyl
new suspensions
Prior art date
Application number
CY20091100839T
Other languages
English (en)
Inventor
BRANDT Sven FA VAN
Emelen Kristof Van
Patrick R Angibaud
Laurence FB MARCONNET-DECRANE
Janine Arts
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39294123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110358(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1110358T1 publication Critical patent/CY1110358T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Αυτή η εφεύρεση περιλαμβάνει τις νέες ενώσεις του τύπου (I) όπου τα R1, R2, R3, R4 και Χ έχουν καθορισμένες σημασίες, οι οποίες έχουν ενζυματική δράση αναστολής αποακετυλάσης ιστόνης· την παρασκευή τους, συνθέσεις που τις περιέχουν και τη χρήση τους ως φάρμακο.
CY20091100839T 2004-07-28 2009-08-06 Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης CY1110358T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04077171 2004-07-28
US59235704P 2004-07-29 2004-07-29
EP05777776A EP1776358B1 (en) 2004-07-28 2005-07-25 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase

Publications (1)

Publication Number Publication Date
CY1110358T1 true CY1110358T1 (el) 2015-04-29

Family

ID=39294123

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100839T CY1110358T1 (el) 2004-07-28 2009-08-06 Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης

Country Status (26)

Country Link
EP (1) EP1776358B1 (el)
JP (1) JP5279268B2 (el)
KR (1) KR101282833B1 (el)
CN (1) CN1993356B (el)
AR (1) AR050189A1 (el)
AT (1) ATE432274T1 (el)
AU (1) AU2005266311B2 (el)
BR (1) BRPI0513891B8 (el)
CA (1) CA2572971C (el)
CY (1) CY1110358T1 (el)
DE (1) DE602005014646D1 (el)
DK (1) DK1776358T3 (el)
EA (1) EA011932B1 (el)
ES (1) ES2327253T3 (el)
HK (1) HK1106236A1 (el)
HR (1) HRP20090439T1 (el)
IL (1) IL180961A0 (el)
MX (1) MX2007001119A (el)
MY (1) MY142831A (el)
NO (1) NO20071117L (el)
NZ (1) NZ552758A (el)
PL (1) PL1776358T3 (el)
PT (1) PT1776358E (el)
SI (1) SI1776358T1 (el)
TW (1) TWI394752B (el)
WO (1) WO2006010749A2 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL208401B1 (pl) 2002-03-13 2011-04-29 Janssen Pharmaceutica Nv Pochodne piperazynylowe, piperydynylowe i morfolinylowe, sposób ich wytwarzania, kompozycja je zawierająca oraz ich zastosowanie
CA2476296C (en) 2002-03-13 2011-02-22 Janssen Pharmaceutica N.V. Amino-derivatives as inhibitors of histone deacetylase
ES2306880T3 (es) 2002-03-13 2008-11-16 Janssen Pharmaceutica Nv Derivados de sulfonilamino como inhibidores novedosos de la histona desacetilasa.
KR101261305B1 (ko) 2004-07-28 2013-05-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
WO2006122926A1 (en) 2005-05-18 2006-11-23 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
WO2007049262A1 (en) * 2005-10-27 2007-05-03 Berand Limited Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
US7834025B2 (en) 2006-01-19 2010-11-16 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
AU2007206944B2 (en) 2006-01-19 2012-08-23 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CN101370790B (zh) * 2006-01-19 2015-10-21 詹森药业有限公司 作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物
ES2327972T3 (es) 2006-01-19 2009-11-05 Janssen Pharmaceutica, N.V. Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
EP1839656A1 (en) * 2006-03-31 2007-10-03 TopoTarget Germany AG Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
CA2703718A1 (en) 2007-11-02 2009-05-07 Tammy Mallais Inhibitors of histone deacetylase
CN101723896B (zh) * 2009-11-03 2012-10-31 山东大学 酪氨酸衍生物类组蛋白去乙酰化酶抑制剂及其应用
WO2012117421A1 (en) 2011-03-02 2012-09-07 Orchid Research Laboratories Ltd Histone deacetylase inhibitors
KR101419836B1 (ko) * 2012-05-10 2014-07-16 서울대학교산학협력단 Δ5-2-옥소피페라진 유도체를 포함하는 중간엽 줄기세포의 연골세포로의 분화 유도용 조성물
KR101586045B1 (ko) 2013-07-30 2016-01-15 충북대학교 산학협력단 신규 페닐티아졸 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물
KR102132078B1 (ko) 2018-09-20 2020-07-08 원광대학교산학협력단 방향족 화합물, 아민 및 친핵체를 이용한 3가지 성분 반응으로 1-에틸-4-페닐피페라진 유도체를 제조하는 방법
KR20230155311A (ko) 2022-05-03 2023-11-10 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
KR20230155310A (ko) 2022-05-03 2023-11-10 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
PL208401B1 (pl) * 2002-03-13 2011-04-29 Janssen Pharmaceutica Nv Pochodne piperazynylowe, piperydynylowe i morfolinylowe, sposób ich wytwarzania, kompozycja je zawierająca oraz ich zastosowanie
CA2476296C (en) * 2002-03-13 2011-02-22 Janssen Pharmaceutica N.V. Amino-derivatives as inhibitors of histone deacetylase
AU2003229883B2 (en) * 2002-04-03 2009-06-11 Topotarget Uk Limited Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors

Also Published As

Publication number Publication date
NZ552758A (en) 2009-08-28
CA2572971A1 (en) 2006-02-02
BRPI0513891B8 (pt) 2021-05-25
EP1776358B1 (en) 2009-05-27
NO20071117L (no) 2007-02-27
HK1106236A1 (en) 2008-03-07
WO2006010749A3 (en) 2006-06-08
CN1993356A (zh) 2007-07-04
TWI394752B (zh) 2013-05-01
AU2005266311A1 (en) 2006-02-02
WO2006010749A2 (en) 2006-02-02
ATE432274T1 (de) 2009-06-15
DK1776358T3 (da) 2009-09-07
PT1776358E (pt) 2009-08-13
EP1776358A2 (en) 2007-04-25
BRPI0513891A (pt) 2008-05-20
MX2007001119A (es) 2007-03-15
ES2327253T3 (es) 2009-10-27
CA2572971C (en) 2013-01-15
SI1776358T1 (sl) 2009-10-31
JP2008508234A (ja) 2008-03-21
MY142831A (en) 2011-01-14
KR101282833B1 (ko) 2013-07-08
HRP20090439T1 (hr) 2009-09-30
CN1993356B (zh) 2010-10-27
EA011932B1 (ru) 2009-06-30
PL1776358T3 (pl) 2009-10-30
TW200616998A (en) 2006-06-01
JP5279268B2 (ja) 2013-09-04
DE602005014646D1 (de) 2009-07-09
AR050189A1 (es) 2006-10-04
IL180961A0 (en) 2007-07-04
EA200700143A1 (ru) 2007-06-29
AU2005266311B2 (en) 2011-08-11
KR20070043978A (ko) 2007-04-26
BRPI0513891B1 (pt) 2020-09-29

Similar Documents

Publication Publication Date Title
CY1110358T1 (el) Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης
PL370991A1 (en) New inhibitors of histone deacetylase
PL371100A1 (en) Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
PL370982A1 (en) Carbonylamino-derivatives as novel inhibitors of histone deacetylase
PL371036A1 (en) Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
MXPA04007775A (es) Derivados de sulfonilo como novedosos inhibidores de la histona desacetilasa.
DK1899325T3 (da) Imidazolinon- og hydantoinderivater som hidtil ukendte hæmmere af histondeacetylase
UA86066C2 (ru) Производные замещенного пропенилпиперазина как ингибиторы гистондеацетилазы
CY1109331T1 (el) Παραγωγα αμινοφαινυλιου ως νεοι αναστολεις της αποακετυλασης ιστονης
ATE539073T1 (de) Heterocyclylalkylderivate als neue inhibitoren von histondeacetylase
ATE509920T1 (de) Quadratsäurederivate als inhibitoren von histondeacetylase
HK1106234A1 (en) Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
NO20072058L (no) Inhibitorer av interaksjonen mellom MDM2 og P53
NO20070555L (no) Kinazolinonderivater som parp-inhibitorer
NO20072605L (no) Nytt antranilinsyrederivat eller et salt derav
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
CY1106343T1 (el) Παραγωγα νικοτιναμιδιου χρησιμα σαν pde4 αναστολεις
DK1896416T3 (da) Substituerede heterocykliske forbindelser, deres anvendelse som medikament og farmaceutiske præparater, der omfatter disse
WO2006078887A3 (en) Methylphenidate derivatives and uses of them
NO20081103L (no) 9-Aminoklarbonylsubstituerte derivater av glycylcykliner
ATE542812T1 (de) Substituierte indolylalkylaminoderivate als neue inhibitoren von histondeacetylase
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
DE602004009306D1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern